New blood test could spot bleeding risk in Moms-to-Be faster
NCT ID NCT06255496
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new device called Quantra QStat that measures how well blood clots, compared to standard lab tests. It involved 296 pregnant women or new mothers at risk of heavy bleeding during delivery. The goal was to see if the new device gives faster and reliable results to help doctors manage bleeding emergencies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD LOSS MASSIVE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Magee Womens Hospital
Pittsburgh, Pennsylvania, 15213, United States
-
Ohio State University Wexner Medical Center
Columbus, Ohio, 43210, United States
-
Parkland Health
Dallas, Texas, 75235, United States
-
University of Oklahoma Medical Center
Oklahoma City, Oklahoma, 73104, United States
-
University of Rochester Medical Center
Rochester, New York, 14642, United States
-
University of Utah
Salt Lake City, Utah, 84112, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple kit cut newborn deaths by 25%? a major trial in pakistan aims to find out
- Could a pill under the tongue prevent dangerous bleeding after birth?
- Could a new drug beat the standard for preventing postpartum hemorrhage?
- Could a simple drug cocktail stop postpartum bleeding?
- Finger-Stick and phone app could replace needles for anemia in pregnancy
- New uterine drain shows promise in reducing Post-C-Section bleeding